Your browser doesn't support javascript.
loading
Understanding mechanisms of primary resistance to checkpoint inhibitors will lead to precision immunotherapy of advanced gastric cancer.
Gambardella, V; Fleitas, T; Cervantes, A.
Afiliação
  • Gambardella V; CIBERONC, Madrid; Department of Medical Oncology, Biomedical Research Institute Incliva, University of Valencia, Valencia, Spain.
  • Fleitas T; CIBERONC, Madrid; Department of Medical Oncology, Biomedical Research Institute Incliva, University of Valencia, Valencia, Spain.
  • Cervantes A; CIBERONC, Madrid; Department of Medical Oncology, Biomedical Research Institute Incliva, University of Valencia, Valencia, Spain. Electronic address: cervante@uv.es.
Ann Oncol ; 30(3): 351-352, 2019 03 01.
Article em En | MEDLINE | ID: mdl-30657856
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Neoplasias Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Neoplasias Idioma: En Ano de publicação: 2019 Tipo de documento: Article